Abstract
Caroline Hesselager, Ingrid Thörn, Millaray Marincevic, Claes Ladenvall, Jonas Almlöf, Sara Löfgren, Simone Weström, Helena Nord, Lesley-Ann Sutton, Lucia Cavelier, Panagiotis Baliakas, Rose-Marie Amini
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
T-cell prolymphocytic leukemia: epidemiology and survival trends in the era of novel treatments
10.1002/ajh.27205 · 2024
Advances in cellular therapy for T-cell prolymphocytic leukemia
10.3389/fonc.2022.781479 · 2022
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
10.1182/blood.2019000402 · 2019
Long-smoldering T-prolymphocytic leukemia: a case report and a review of the literature
10.3390/curroncol30110727 · 2023
Outcomes of allogeneic hematopoietic cell transplantation in T cell prolymphocytic leukemia: a contemporary analysis from the Center for International Blood and Marrow Transplant Research
10.1016/j.jtct.2022.01.017 · 2022
Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia
10.1002/ajh.26918 · 2023
Novel precision medicine approaches and treatment strategies in hematological malignancies
10.1111/joim.13697 · 2023
JAK/STAT-activating genomic alterations are a hallmark of T-PLL
10.3390/cancers11121833 · 2019
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study
10.1182/bloodadvances.2023012248 · 2024
Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
10.1186/s12885-019-5529-0 · 2019
Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
10.1002/ajh.25927 · 2020
Somatic exonic deletions in RUNX1 constitutes a novel recurrent genomic abnormality in acute myeloid leukemia
10.1158/1078-0432.ccr-23-0122 · 2023
How to manage patients with germline DDX41 variants: recommendations from the Nordic Working Group on germline predisposition for myeloid neoplasms
10.1002/hem3.145 · 2024
Patient-specific measurable residual disease markers predict outcome in patients with myelodysplastic syndrome and related diseases after hematopoietic stem-cell transplantation
10.1200/jco.23.01159 · 2024
Five percent variant allele frequency is a reliable reporting threshold for TP53 variants detected by next generation sequencing in chronic lymphocytic leukemia in the clinical setting
10.1097/hs9.0000000000000761 · 2022
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
10.1038/s41467-017-02688-6 · 2018
Genomics of resistance to targeted therapies
10.1016/j.hoc.2021.03.004 · 2021
Evolutionary dynamics of chronic myeloid leukemia
10.1177/1947601910371122 · 2010
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
10.1038/s41467-020-19119-8 · 2020
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
10.1182/blood-2014-03-559542 · 2014
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
10.1111/bjh.13952 · 2016
Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and T-prolymphocytic leukemia presenting with lymphocytosis, skin lesions, and generalized lymphadenopathy
2019
The incidence and gene frequency of ataxia-telangiectasia in the United States
1986
Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers
10.1111/bjh.18419 · 2022
No additional external references are available.